Zydus Lifesciences receives final approval from US FDA for Cyanocobalamin injection The injection is used to treat and prevent lack of vitamin B12 that may be caused due to pernicious anaemia, certain diseases, infections or medications decrease the amount of vitamin B12 absorbed from food Zydus Lifesciences has received final approval from the US Food and Drug Administrration (FDA) to market Cyanocobalamin injection in the strengths of 1,000 mcg/mL,10,000 mcg/10 mL (1,000 mcg/mL), and 30,000 mcg/30 mL (1,000 mcg/mL) multiple-dose vials, a company statement said
BPC-157 is derived from gastric proteins and has particularly strong effects on the GI tract, tendons, and ligaments
Its multifaceted nature and relatively low-risk profile make it a compelling candidate for therapeutic intervention across several medical contexts
A damaged seal, suspected contamination, or questionable sterility
Pregnancy or breastfeeding: Do not use
Excellent product and service I absolutely love the skinny shot combo